In addition, in human pancreatic cancer and mouse pancreatic tumor models (Pan02), the CCL5 level on tumor cells is elevated, while CD4+Foxp3– effector T cells preferentially express C‐C chemokine receptor 5 (CCR5). This evidence concerns the gene CCL5 and pancreatic neoplasm.